Keywords: Oxidative stress; Redox active iron; Iron sucrose; Catalase; Deferoxamine; Chelators;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 89Zr; PET imaging; Medical isotope; Laboratory automation; Hydroxamate; Anion exchange; Deferoxamine;
Keywords: Dual release system; Mesoporous silicate nanoparticles; Nanofibrous scaffold; Angiogenesis; Osteogenesis; Deferoxamine;
Keywords: TfR1; transferrin receptor 1; Dmt1; divalent metal transporter 1; HIF-1α; hypoxia-inducible factor; IRP; iron regulatory protein; LIP; labile iron pool; FTH; ferritin heavy chain; FTL; ferritin light chain; Fpn1; ferroportin-1; Lcn2; lipocalin-2; 2; 5-DH
Keywords: Intranasal; Alzheimer; Galantamine; Deferoxamine; Risperidone; Donepezil;
Keywords: DFP; deferiprone; HD; Huntington's disease; PD; Parkinson's disease; AD; Alzheimer's disease; TBARS; thiobarbituric acid-reactive substances; ABCB8; ATP binding cassette subfamily B member 8; ISC; iron-sulfur cluster; SDH; succinate dehydrogenase; LDH; la
Keywords: ABC; adenosine triphosphate-binding cassette; ACP; Ananas comosus peels; AHT; Arachis hypogaea twigs; IARC; According to the International Agency for Research on Cancer; ArHL; Artocarpus heterophyllus leaves; BCRP; breast cancer resistance protein; CLR; C
Keywords: IRP2; Iron; Hypoxia; Ovarian endometrial cyst; DFO; deferoxamine; FAS; ferrous ammonium sulfate; FBS; fetal bovine serum; Fe2+; ferrous iron; HIF-1; hypoxia-inducible factor 1; IRP; iron regulatory protein; CA9; Carbonic anhydrase 9; PBS; phosphate buffer
Keywords: antioxidant; deferoxamine; osteoarthritis; oxidative stress; quercetin; vitamin C;
Keywords: Multiple myeloma; Pharmacologically-dosed ascorbic acid; Apoptosis-inducing factor 1; MM; multiple myeloma; ROS; reactive oxygen species; SMM; smoldering MM; IMIDs; immunomodulatory drugs; ASCT; autologous stem cell transplantation; CRs; complete remissio
Keywords: AL; acute leukemia; ALL; acute lymphoblastic leukemia; ALT; alanine aminotranferase; AML; acute myeloid leukemia; AST; aspartate aminotransferase; CHF; congestive heart failure; CRP; C-reactive protein; DFO; deferoxamine; DFS; disease-free survival; DFX;
Keywords: Ascaridole (Pubchem CID: 10545); Artemisinin (Pubchem CID: 68827); ACN; acetonitrile; Art; artemisinin; Asc; ascaridole; BHI; brain heart infusion; CDCl3; deuterated chloroform; Cin; 1,4-cineole; Cys; cysteine; DFO; deferoxamine; DMEM; Dulbecco's Modifi
Keywords: Intranasal; Deferoxamine; Streptozotocin; GSK3β; Oxidation; Insulin;
Keywords: 4-HNE; 4-hydroxy-2-nonenal; 6-OHDA; 6-hydroxydopamine; BSO; buthioninesulfoximine; DFO; Deferoxamine; DMT1; divalent metal transporter 1; ELISA; enzyme-linked immunosorbent assay; FPN1; Ferroportin 1; IRE; iron responsive element; IRP; iron regulatory pro
Keywords: Radiotherapy; Osteoradionecrosis; Pathologic fracture; Nonunion; Deferoxamine; Amifostine;
Keywords: aCSF; artificial cerebrospinal fluid; DFX; deferoxamine; Fe; iron; Fe2+; ferrous iron; Fe3+; ferric iron; FJC; Fluoro-Jade C; Hb; hemoglobin; H&E; hematoxylin and eosin; IVH; intraventricular hemorrhage; JNK; c-Jun N-terminal kinase; MRI; magnetic resonan
Keywords: Alginate; Deferoxamine; Oxidation response; Stability; Toxicity;
Keywords: Single-walled carbon nanotubes; Carbon nanotubes; Nanomaterials; Nanotoxicology; Pulmonary toxicology; Inflammation; Oxidative stress; Inhalation; Pharyngeal aspiration; Intratracheal instillation; ACE; angiotensin-converting enzyme; AD-SWCNTs; acetone/so
Keywords: ARDS; acute respiratory distress syndrome; CoCl2; cobalt chloride; DFO; deferoxamine; DMOG; dimethyloxalyglycin; DPI; diphenylene iodonium; FCS; fetal calf serum; FFA; free fatty acid; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; G3PDH; glycerol-3-pho
Keywords: DCF; dichlorofluorescein; DFO; deferoxamine; DHR-123; dihydrorhodamine 123; FAC; ferric ammonium citrate; iNs; induced neurons; IRP1; iron regulatory protein 1; LIP; labile iron pool; NBIA; neurodegeneration with brain iron accumulation; PKAN; pantothenat
Keywords: AML; acute myeloid leukemia; BSA; bovine serum albumin; DPF; deferiprone (3-hydroxy-1,2-dimethyl-4-pyridinone); DFO; deferoxamine; ESA; erythropoietic stimulating agents; EDTA; ethylene-diamine tetracetate; FAC; ferric ammonium citrate; FIC; functional ir
Keywords: Asc-2P; ascorbate-2-phosphate; DFO; deferoxamine; DHA; dehydroascorbic acid; DPD; 2,2â²-dipyridyl; 8-HQ; 8-hydroxyquinoline; DTPA; diethylenetriaminepentaacetic acid; PG SK; Phen Green SK diacetate;
Keywords: Iron overload cardiomyopathy; Iron chelator; Deferoxamine; Deferiprone; Deferasirox; Antioxidant;
Keywords: Chemiluminescence; Deferoxamine; Free radicals; Photon production; Stern–Volmer plot
Keywords: TFR1; Ferroportin; Hyperthermia; Deferoxamine; Aging; DMT1
Keywords: MDS; Myelodysplastic syndrome; Iron chelation; Iron overload; Transfusion-dependent; Deferasirox; Deferoxamine; Deferiprone
Keywords: LIP; labile iron pool; FAC; Ferric Ammonium Citrate; DCF-DA; dichlorofluorescein-diacetate; PI; propidium iodide; IO; iron-overloaded; MFPs; mammary fat pads; IP; intraperitoneal injection; CA-AM; calcein acetoxymethyl ester; FACS; Fluorescence Activated
Keywords: Thalassemia major; Sickle cell disease; Iron overload; Iron chelation; Deferoxamine; Deferiprone; Deferasirox;
Keywords: Iron overload; Thalassemia; Sickle cell disease; Deferoxamine; Deferiprone; Deferasirox; Surcharge en fer; Thalassémie; Drépanocytose; Deferoxamine; Deferiprone; Deferasirox;
Keywords: Heavy metal; DMSA; DMPS; Penicillamine; Deferoxamine
Keywords: DMSA; DMPS; Deferiprone; Deferasirox; Deferoxamine
Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis
Keywords: Injectable hydrogel; Chitosan; Hyaluronic acid; Coacervate hydrogel; Deferoxamine; Angiogenesis; Neo-vascularization;
Hydroxamate column-based purification of zirconium-89 (89Zr) using an automated fluidic platform
Keywords: Zirconium-89; 89Zr; ImmunoPET; Medical isotope; Laboratory automation; Hydroxamate; Deferoxamine;
Metal-based BODIPY derivatives as multimodal tools for life sciences
Keywords: acac; acetylacetonate; BMDC; bone marrow derived dendritic cell; BODIPY; boron dipyrromethene, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; bpy; 2,2â²-dipyridyl; BSA; bovine serum albumin; cat; catechol; CLSM; confocal laser scanning microscopy; CT; compu
LDL dinitrosyl iron complex acts as an iron donor in mouse macrophages
Keywords: CDIP; calcein-chelatable divalent ion pool; LDL; low-density lipoprotein; oxLDL; oxidized low-density lipoprotein; nLDL; native low-density lipoprotein; DNIC; dinitrosyl iron complex; DNICLDL; dinitrosyl iron complex of low-density protein; iNOS; inducibl
An impedimetric biosensor for DNA damage detection and study of the protective effect of deferoxamine against DNA damage
Keywords: DNA damage; Au nanoparticles; Screen printed gold electrode; Deferoxamine;
Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo
Keywords: Deferoxamine; Macromolecule; Pharmacokinetics; Biodistribution; Iron chelation;
To chelate or not to chelate in MDS: That is the question!
Keywords: Myelodysplastic syndromes; Transfusion; Iron chelation; Deferasirox; Deferoxamine; Deferiprone;
In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrow
Keywords: Deferoxamine; Mesenchymal stromal cells; ICAM-1; VCAM-1;
Deferoxamine immobilized poly(D,L-lactide) membrane via polydopamine adhesive coating: The influence on mouse embryo osteoblast precursor cells and human umbilical vein endothelial cells
Keywords: Poly(D,L-lactide); Deferoxamine; Polydopamine; Surface modification; Osteogenesis; Angiogenesis;
67Ga-labeled deferoxamine derivatives for imaging bacterial infection: Preparation and screening of functionalized siderophore complexes
Keywords: Bacterial infection; Imaging; SPECT; Gallium-67; Siderophore; Deferoxamine;
Deferoxamine-conjugated AgInS2 nanoparticles as new nanodrug for synergistic therapy for hepatocellular carcinoma
Keywords: Iron chelator; AgInS2 nanoparticle; Deferoxamine; Liver cancer; Synergistic therapy;
Heme oxygenase-1 metabolite biliverdin, not iron, inhibits porcine reproductive and respiratory syndrome virus replication
Keywords: PRRSV; porcine reproductive and respiratory syndrome virus; PAM; porcine alveolar macrophage; MARC-145; african green monkey kidney cells; HO-1; heme oxygenase-1; ROS; reactive oxygen species; BV; biliverdin; BR; bilirubin; Hb; hemoglobin; NO; nitric oxid
Deferoxamine improves antioxidative protection in the brain of neonatal rats: The role of anoxia and body temperature
Keywords: Deferoxamine; Antioxidant enzymes; Neonatal anoxia; Hyperthermia;
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib
Keywords: AFP; alpha-feto protein; AREG; amphiregulin; ATF6; activating transcription factor-6; DFX; deferoxamine; eIF-2α; eukaryotic translation initiation factor-2α; ERK1/2; extracellular signal-regulated kinase 1/2; IRE-1α; inositol-requiring enzyme-1α; GRP;
Iron distribution and histopathological study of the effects of deferoxamine and deferiprone in the kidneys of iron overloaded β-thalassemic mice
Keywords: Beta-knockout mice; Deferoxamine; Deferiprone; Kidney pathology; Iron overload;
Iron depletion in HCT116 cells diminishes the upregulatory effect of phenethyl isothiocyanate on heme oxygenase-1
Keywords: Deferoxamine; Heme oxygenase-1; Iron; Phenethyl isothiocyanate
Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1α activation in hepatic ischemia/reperfusion injury
Keywords: I/R; ischemia/reperfusion; ROS; reactive oxygen species; SEVO; sevoflurane; PROP; propofol; PTP; permeability transition pore; HIF-1α; hypoxia-inducible factor 1 alpha; DFX; deferoxamine; ALT; alanine aminotransferase; AST; aspartate aminotransferase; GS
A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload
Keywords: AD; Alzheimer's disease; APP; amyloid precursor protein; Aβ; amyloid-β; BBB; blood-brain barrier; DFO; deferoxamine; DFP; deferiprone; DFX; deferasirox; Drp1; dynamin-related protein 1; HFe; high-iron diet; Mfn2; mitofusin2; NAC; n-acetyl cysteine;
Deferoxamine pre-treatment protects against postoperative cognitive dysfunction of aged rats by depressing microglial activation via ameliorating iron accumulation in hippocampus
Keywords: Postoperative cognitive dysfunction; Deferoxamine; Iron accumulation; Aging; Hippocampus